Literature DB >> 12477472

The effect of patient and tumour characteristics on visualization of sentinel nodes after a single intratumoural injection of Tc 99m labelled human albumin colloid in breast cancer.

E Leppänen1, M Leidenius, L Krogerus, K von Smitten.   

Abstract

AIMS: The aim of the study was to study the influence of patient- or tumour-related factors on the lymphatic drainage patterns in breast cancer.
METHODS: The study included 290 consecutive breast cancer patients with lymphatic mapping and sentinel node biopsy. Lymphoscintigraphy was performed a median of four hours after a single intratumoral injection of (99m)Tc labelled human albumin colloid with two different particle sizes.
RESULTS: Lymphoscintigraphy showed axillary sentinel nodes in 253 (87%) and parasternal sentinel nodes in 49 (17%) patients. The median number of nodes seen in the axilla was one (range 0-5). No sentinel nodes were visualized in 27 (9%) patients. The number of the visualized axillary nodes was influenced by the particle size of the radiocolloid, and by metastatic involvement of the axillary nodes and the age and body mass index (BMI) of the patient. Patients with parasternal sentinel nodes were younger, had a lower BMI and had more often a non-palpable tumour.
CONCLUSIONS: The age and BMI of the patient and the palpability of the tumour influence lymphatic drainage patterns in breast cancer. The metastatic involvement of axillary nodes seems to modify lymphatic drainage to the axilla.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12477472     DOI: 10.1053/ejso.2002.1325

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

1.  Internal mammary chain drainage of breast cancer.

Authors:  Borys R Krynyckyi; Jungho Shim; Chun K Kim
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

2.  Results of preoperative lymphoscintigraphy for breast cancer are predictive of identification of axillary sentinel lymph nodes.

Authors:  Frédéric Marchal; Philippe Rauch; Olivier Morel; Jean Claude Mayer; Pierre Olivier; Agnès Leroux; Jean Luc Verhaeghe; François Guillemin
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

3.  Factors of importance for scintigraphic non-visualisation of sentinel nodes in breast cancer.

Authors:  A H Chakera; E Friis; U Hesse; N Al-Suliman; B Zerahn; B Hesse
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-05       Impact factor: 9.236

4.  Impact of patient- and disease-specific factors on SLNB in breast cancer patients. Are current guidelines justified?

Authors:  A Bembenek; J Fischer; H Albrecht; E Kemnitz; S Gretschel; U Schneider; S Dresel; P M Schlag
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

5.  99mTc-phytate is better than 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer.

Authors:  Hiroyuki Takei; Kimito Suemasu; Masafumi Kurosumi; Jun Ninomiya; Yoshio Horii; Kenichi Inoue; Toshio Tabei
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

6.  Impact of Tumor Localization and Method of Preoperative Biopsy on Sentinel Lymph Node Mapping After Periareolar Nuclide Injection.

Authors:  Julia Krammer; Anja Dutschke; Clemens G Kaiser; Andreas Schnitzer; Axel Gerhardt; Julia C Radosa; Joachim Brade; Stefan O Schoenberg; Klaus Wasser
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

7.  Optimization of sentinel lymph node biopsy in breast cancer using an operative gamma camera.

Authors:  Carole Mathelin; Samuel Salvador; Sabrina Croce; Norosoa Andriamisandratsoa; Daniel Huss; Jean-Louis Guyonnet
Journal:  World J Surg Oncol       Date:  2007-11-17       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.